BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Orexo AB 

Box 303

Uppsala    SE-751 05  Sweden
Phone: 46-0-18-780-88-00 Fax: 46-0-18-780-88-88


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Orexo AB (ORXOF) Divests Subsidiary Kibion 4/30/2015 10:50:32 AM
Orexo AB (ORXOF): New 24-Week Clinical Study Strengthens The Evidence Of The Therapeutic Value Of Zubsolv® For Maintenance Treatment Of Opioid Dependence 4/22/2015 2:33:55 PM
Orexo AB (ORXOF) To Present At 2015 Nordic Life Sciences Conference 4/22/2015 2:09:28 PM
Report from Orexo AB (ORXOF)’s Annual General Meeting, 15 April 2015 4/16/2015 1:16:08 PM
Orexo AB (ORXOF)’s Annual Report for 2014 Released 3/25/2015 10:48:56 AM
Notice of Annual General Meeting Of Orexo AB (ORXOF) 3/16/2015 10:50:59 AM
Orexo AB (ORXOF) Broadens ZUBSOLV Product Range and Announces Newly Listed Granted U.S. Patent 2/17/2015 2:18:48 PM
Galena Biopharma  (GALE) Announces Orexo AB (ORXOF)'s Filing Of A Patent Infringement Lawsuit Against Actavis (ACT) Concerning Abstral (Fentanyl) Sublingual Tablets In The U.S. 2/5/2015 7:52:43 AM
Orexo AB (ORXOF): Full Year Report January-December 2014 1/29/2015 11:46:38 AM
Orexo AB (ORXOF) Receives Paragraph IV Notice Letter Concerning Abstral® In The U.S. 1/15/2015 9:40:57 AM
12345678910...